Welcome to LookChem.com Sign In|Join Free

CAS

  • or

59039-64-4

Post Buying Request

59039-64-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59039-64-4 Usage

Medication use

Induction and maintenance of anesthesia

Mechanism of action

Enhances the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, leading to sedation and decreased levels of consciousness

Commonly used in

Surgical procedures and critical care settings

Onset of action

Rapid

Duration of effects

Short

Administration

Intravenously

Recovery time

Quick

Side effects

Respiratory depression, nausea, and vomiting

Associated risks

Adrenal suppression in some patients

Check Digit Verification of cas no

The CAS Registry Mumber 59039-64-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,0,3 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 59039-64:
(7*5)+(6*9)+(5*0)+(4*3)+(3*9)+(2*6)+(1*4)=144
144 % 10 = 4
So 59039-64-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H18N2O/c1-9-3-2-4-10(6-5-9)7-8-11/h11H,2-8H2,1H3

59039-64-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-methyl-1,4-diazepan-1-yl)ethanol

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59039-64-4 SDS

59039-64-4Relevant articles and documents

Compounds II

-

Page/Page column 21, (2009/12/04)

The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 59039-64-4